Portola Pharmaceuticals, Inc.

Q2 2018 13F Holders

Symbol
PTLA
CUSIP
737010108
Type
Equity
Class
COM
Num filings
224
Total reported value, excl. options
$2.37 B
Manager Report Date Value ($000) Shares Option Type